Saint

HomeContact Us Newsletter Sign-up

Our Services Find an Event Find a Physician Health Resources Careers About Us

News & Articles
HealthResources
Pregnancy Health Center
Health References
Procedure Information
Drug Information
News & Articles
Health Tools

Daily Health News Provided by Tenet
Today's Articles: Psychiatry Category Listing >>
Savient Pharmaceuticals Inc acquires exclusive rights to Alzheimer's drug; NIH to provide
Savient Pharmaceuticals Inc has acquired exclusive rights from Marco Hi-Tech JV Ltd to exclusively market in the US and Europe Huperzine-A, a product for the treatment of Alzheimer's disease.
Icogen Receives SBIR Grant for the Identification of Alzheimer's Disease Therapeutic
SEATTLE, July 28 /PRNewswire/ -- Icogen Corporation announced today that it has received an award for a Small Business Innovative Research grant from the National Institute of Aging to develop an Alzheimer's disease therapeutic.
Haunted by ghosts
Schizophrenia often comes to our attention via frightening stories in the media, but it is an illness that can often be managed with the right drugs. ANGELA EGERTON was sitting in the lounge listening to music when a ghost-like figure appeared and started talking to her.
Bereavement-related depression, anxiety and traumatic grief
LONDON By Claire Bennett Dutch researchers have reported that the symptoms of bereavement-related depression, anxiety and traumatic grief are distinct entities which may require different treatments.
MIND & BODY Eilish O'Regan
One in five people has a genetic makeup that makes them particularly vulnerable to the stresses of life, scientists at London University have found.
Lemon Balm may help Alzheimers sufferers
LONDON By Health Newswire reporters The herb Lemon Balm may help improve brain function and reduce agitation in people with mild to moderate Alzheimers disease , say Iranian researchers.
Study Finds That DHA and Fish Consumption Reduces the Risk of Alzheimer Disease
COLUMBIA, Md., July 28 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation today commented on the results of a study published in the July 2003 edition of Archives of Neurology.
Eli Lilly and Company/ New Indication for Zyprexa Receives Positive Opinion from European CPMP
INDIANAPOLIS--(BUSINESS First Treatment in Decades Recommended for the Prevention of Recurrence in Bipolar Disorder Eli Lilly and Company announced today that the European Committee for Proprietary Medicinal Products has issued a positive opinion for a new indication for Zyprexa .
Agency Information Collection Activities/ Submission for OMB Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services Administration will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act .
Category Listing >>